trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

The main challenge in chemical male contraceptives is targeting spermatogenesis without systemic side effects

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Recent advancements in non-hormonal and hormonal male contraceptives focus heavily on precisely targeting spermatogenesis and sperm maturation while avoiding systemic side effects.

The analysis

The retrieved literature consistently emphasizes that developing novel male contraceptives involves finding specific targets within the testis, epididymis, or hormonal axes that disrupt spermatogenesis effectively and reversibly while maintaining a favorable safety profile and avoiding systemic toxicity.

Evidence for · 4
Targeting the retinoid signaling pathway with YCT-529 for effective and reversible oral contraception in mice and primates.
Recorded source metadata

Mannowetz N, Chung SSW, Maitra S, Noman MAA, Wong HL, Cheryala N, Bakshi A, Wolgemuth DJ, Georg GI. Targeting the retinoid signaling pathway with YCT-529 for effective and reversible oral contraception in mice and primates.. 2025. https://doi.org/10.1038/s43856-025-00752-7

Studies on YCT-529 demonstrate successful targeting of spermatogenic pathways with minimal adverse side effects.

See more details
More for · 3
Novel Genes of the Male Reproductive System: Potential Roles in Male Reproduction and as Non-hormonal Male Contraceptive Targets.
Recorded source metadata

Garcia TX, Matzuk MM. Novel Genes of the Male Reproductive System: Potential Roles in Male Reproduction and as Non-hormonal Male Contraceptive Targets.. 2024. https://doi.org/10.1002/mrd.70000

Reviews on novel non-hormonal targets emphasize the pursuit of specific, reversible inhibition without systemic toxicity.

Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1.
Recorded source metadata

Tanis S, Simon LE, Alexander AK, Horan TS, Carro MLM, Bonnett SJ, Xie A, Ben-Shlomo R, Owens CE, Danko CG, Lujic J, Cohen PE. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1.. 2026. https://doi.org/10.1073/pnas.2517498123

Research on the small-molecule inhibitor JQ1 shows that meiotic prophase I can be targeted to disrupt spermatogenesis transiently without lasting reproductive or systemic defects.

Male Hormonal Contraception-Current Stage of Knowledge.
Recorded source metadata

Bania J, Wrona J, Fudali K, Stęga F, Rębisz PF, Murawski M. Male Hormonal Contraception-Current Stage of Knowledge.. 2025. https://doi.org/10.3390/jcm14072188

Investigations into hormonal candidates like DMAU and 11beta-MNTDC focus on achieving effective spermatogenesis suppression while minimizing side effects.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8101 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt